HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ji Woong Choi Selected Research

AUY 954

1/2018Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P1) as a Pathogenic Factor in Transient Focal Cerebral Ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ji Woong Choi Research Topics

Disease

12Brain Ischemia (Cerebral Ischemia)
01/2021 - 08/2012
9Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 06/2008
6Multiple Sclerosis
01/2021 - 10/2010
5Brain Infarction
08/2019 - 01/2015
5Neuroinflammatory Diseases
10/2017 - 07/2008
5Inflammation (Inflammations)
01/2017 - 08/2005
4Ischemic Stroke
01/2022 - 01/2015
4Fibrosis (Cirrhosis)
01/2022 - 01/2010
4Brain Injuries (Brain Injury)
01/2021 - 10/2018
4Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 10/2010
4Neoplasms (Cancer)
11/2020 - 01/2010
3Ischemia
12/2021 - 08/2012
3Alzheimer Disease (Alzheimer's Disease)
12/2020 - 06/2013
3Psoriasis (Pustulosis Palmaris et Plantaris)
11/2020 - 08/2019
3Cognitive Dysfunction
05/2020 - 11/2006
2Gliosis
03/2019 - 04/2018
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
03/2019 - 04/2018
2Demyelinating Diseases (Demyelinating Disease)
04/2018 - 09/2014
2Parkinson Disease (Parkinson's Disease)
04/2018 - 06/2013
2Infarction (Infarctions)
01/2016 - 06/2008
2Mitochondrial Diseases (Mitochondrial Disease)
07/2005 - 01/2005
1Non-alcoholic Fatty Liver Disease
01/2022
1Metabolic Diseases (Metabolic Disease)
01/2022
1Chronic Brain Injury
01/2022
1Reperfusion Injury
12/2021
1Atopic Dermatitis (Atopic Eczema)
12/2021
1Dermatitis
12/2021
1Memory Disorders (Memory Loss)
12/2020
1Wounds and Injuries (Trauma)
11/2020
1Erythema
01/2020
1Sepsis (Septicemia)
10/2018
1Osteoarthritis
08/2017
1Stress Urinary Incontinence
09/2016
1Urinary Incontinence
09/2016
1Stroke (Strokes)
01/2015
1Sinusitis
07/2013
1Myocardial Infarction
07/2013
1Liver Neoplasms (Liver Cancer)
07/2013

Drug/Important Bio-Agent (IBA)

7Lysophosphatidic Acid ReceptorsIBA
01/2021 - 01/2010
6Sphingosine-1-Phosphate ReceptorsIBA
01/2022 - 01/2011
6sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2022 - 01/2011
6Neuroprotective AgentsIBA
01/2022 - 08/2012
5Fingolimod Hydrochloride (FTY720)FDA Link
01/2021 - 10/2010
5Small Interfering RNA (siRNA)IBA
12/2020 - 01/2016
4InflammasomesIBA
01/2022 - 01/2020
4Proteins (Proteins, Gene)FDA Link
12/2019 - 02/2011
3Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA
10/2017 - 09/2014
3Matrix Metalloproteinases (MMPs)IBA
10/2017 - 09/2014
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2022 - 09/2011
2Therapeutic UsesIBA
01/2022 - 01/2015
2Mitogen-Activated Protein KinasesIBA
12/2021 - 03/2012
2EnzymesIBA
01/2021 - 01/2010
2Amyloid (Amyloid Fibrils)IBA
12/2020 - 12/2019
2Pharmaceutical PreparationsIBA
10/2020 - 01/2019
2Scopolamine (Hyoscine)FDA Link
05/2020 - 12/2019
2lysophosphatidic acidIBA
01/2020 - 09/2011
2shogaolIBA
03/2019 - 01/2015
26-paradolIBA
03/2019 - 01/2015
2Messenger RNA (mRNA)IBA
04/2018 - 01/2016
2eupatilinIBA
01/2017 - 08/2012
2Glucose (Dextrose)FDA LinkGeneric
06/2008 - 01/2005
2Peroxynitrous Acid (Peroxynitrite)IBA
08/2005 - 07/2005
2Adenosine (Adenocard)FDA LinkGeneric
07/2005 - 01/2005
1Oleanolic AcidIBA
01/2022
1Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2021
1Protein SIBA
12/2021
1Oxygen (Dioxygen)IBA
12/2021
1CytokinesIBA
12/2021
1Dinitrochlorobenzene (DNCB)IBA
12/2021
1ChemokinesIBA
12/2021
1NF-kappa B (NF-kB)IBA
12/2021
1Volatile Oils (Essential Oils)IBA
12/2021
1Receptor for Advanced Glycation End ProductsIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020
1NucleotidesIBA
11/2020
1Imiquimod (Aldara)FDA LinkGeneric
01/2020
1Dopamine (Intropin)FDA LinkGeneric
12/2019
1Monoamine Oxidase (MAO)IBA
12/2019
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
12/2019
13,4-dihydroxyphenyllactic acidIBA
12/2019
1protein kinase modulatorIBA
12/2019
1SphingosineIBA
06/2019
1Pertussis ToxinIBA
03/2019
1Peptides (Polypeptides)IBA
03/2019
1Myelin-Oligodendrocyte GlycoproteinIBA
03/2019
1CAY10444IBA
10/2018
1Glucagon-Like Peptide-1 ReceptorIBA
04/2018
1Exenatide (Byetta)FDA Link
04/2018
1Complement System Proteins (Complement)IBA
04/2018
1Glucagon-Like Peptide 1 (GLP 1)IBA
04/2018
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2018
1AUY 954IBA
01/2018
1LipopolysaccharidesIBA
01/2017

Therapy/Procedure

3Therapeutics
11/2020 - 01/2011
2Oral Administration
01/2018 - 01/2017
1Immunotherapy
11/2020
1Debridement
08/2017
1Arthroplasty
08/2017
1Suburethral Slings (Tension-Free Vaginal Tape)
09/2016
1Renal Dialysis (Hemodialysis)
07/2013